article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most importantly the high failure rate. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.

article thumbnail

The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good 

Bill Of Health

The COVID-19 pandemic has laid bare the lack of regulation for the sharing of intellectual property (IP) and technology needed for an effective and equitable response to the crisis. Multinational pharmaceutical companies have declined collaboration with C-TAP and with the WHO mRNA hubs on COVID-19 vaccines. By Ellen ‘t Hoen.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill Of Health

Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health law and policy issues. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology.

article thumbnail

What is DARWIN EU?

Healthcare ECONOMIST

By supporting decision-making on the development, authorisation and surveillance of medicines, a wide range of stakeholders will benefit, from patients and healthcare professionals to health technology assessment bodies and the pharmaceutical industry. Arlett et al. The DARWIN EU advisory board members are listed here.

article thumbnail

Digital Health in Japan and Korea – Where Is It Heading?

Health Advances

A large and aging population advanced IT infrastructure, and a single national healthcare system are among the features that will make Japan and South Korea ideal candidates to adopt digital health technologies at scale. Telemedicine in Korea is regulated by Medical Service Act and Personal Information Protection Act.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill Of Health

Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to identify interesting empirical studies, policy analyses, and editorials on health law and policy issues relevant to current or potential future work in the Division. Value Health. Kesselheim.

article thumbnail

Roundups: 16 Recent Strategic Digital Health Partnerships

HIT Consultant

The CCPC project aims to allow patients to continue their care at home after discharge through the development of new predictive analytics, AI, and home monitoring technology that integrates with current medical systems for uninterrupted care from hospital to home. FIGS, Inc. ,